Study details
Enrolling now
Neuromodulation and Cognitive Training in Opioid Use Disorder
University of Minnesota
NCT IDNCT03773523ClinicalTrials.gov data as of Apr 2026
Target enrollment
30
Study length
about 6.8 years
Ages
18–60
Locations
1 site in MN
What this study is about
This trial is testing if neuromodulation, specifically transcranial direct current stimulation (tDCS), can help people with opioid use disorder. The goal is to improve treatment outcomes by targeting brain changes that lead to relapse.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Use Transcranial Direct Current Stimulation (tDCS)
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Primary: Change in brain functional connectivity as measured by functional magnetic resonance imaging
Devices
therapeutic
Body systems
Psychiatry / Mental Health